Skip to main content
AAN.com

Abstract

We examined the baseline characteristics of patients in the Ticlopidine Aspirin Stroke Study (TASS) to determine if the effects of the two treatments in preventing stroke differed in various subgroups. Patients with the following characteristics did less well on aspirin: elevated creatinine, hypertension or diabetes requiring treatment, or treatment with anticoagulant or antiplatelet drugs prior to their qualifying TIA or stroke. Women and patients with vertebrobasilar symptoms did particularly well on ticlopidine. We performed arteriography in 1,188 patients with carotid qualifying events. The frequency of stroke in patients with abnormal arteriograms ipsilateral to their symptoms was slightly higher than in those with normal carotid arteries. Ticlopidine was more effective in patients without carotid stenosis. Ticlopidine is more effective than aspirin in preventing strokes in patients having warning TIAs. The patients who benefit most from ticlopidine may be women, those who have vertebrobasilar symptoms, those with cerebral ischemic symptoms while on aspirin or anticoagulant therapy, and patients with diffuse atherosclerotic disease rather than high-grade carotid stenosis.

Get full access to this article

View all available purchase options and get full access to this article.

Information & Authors

Information

Published In

Neurology®
Volume 42Number 1January 1992
Pages: 111
PubMed: 1734290

Publication History

Published online: January 1, 1992
Published in print: January 1992

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

TASS Baseline and Angiographic Data Subgroup
From the Department of Neurology (Dr. Grotta), University of Texas Medical School, Houston, TX; Department of Neurology (Dr. Norris), University of Toronto, Toronto, ON, Canada; and Syntex Research (B. Kamm), Palo Alto, CA.
* Members of the Tass Baseline and Angiographic Data Subgroup: H.P. Adams, Iowa City, IA; B.A. Anderson, Winnipeg, MB, Canada; A. Bellavance, St. Lambert, PQ, Canada; J.A. Byer, Columbia, MO; J.R. Couch, Springfield, IL; B.H. Dobkin, Los Angeles, CA; M.J. Fisher, Los Angeles, CA; G.R. Hanna, Charlottesville, VA; L.A. Hershey, Cleveland, OH; C.S. Kase, Boston, MA; J.R. Lacy, Palo Alto, CA; L.L. Levy, West Haven, CT; C. Mayman, Boston, MA; J.S. Meyer, Houston, TX; C.P. Olinger, Cincinnati, OH; W. Pryse-Phillips, St. Johns, NF, Canada; J.T. Robertson, Memphis, TN; J.F. Rothrock, San Diego, CA; C.H. Sadowsky, Palm Beach, FL; P.D. Swanson, Seattle, WA; J. Taylor, Richmond, VA; and L.A. Weisberg, New Orleans, LA.

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Melatonin alleviates valproic acid-induced neural tube defects by modulating Src/PI3K/ERK signaling and oxidative stress, Acta Biochimica et Biophysica Sinica, (2023).https://doi.org/10.3724/abbs.2023234
    Crossref
  2. NMDA Receptor Signaling Is Important for Neural Tube Formation and for Preventing Antiepileptic Drug-Induced Neural Tube Defects, The Journal of Neuroscience, 38, 20, (4762-4773), (2018).https://doi.org/10.1523/JNEUROSCI.2634-17.2018
    Crossref
  3. Lamotrigine Use in Pregnancy, Journal of Pharmacy Technology, 15, 3, (75-78), (2016).https://doi.org/10.1177/875512259901500302
    Crossref
  4. Stroke Management, Journal of Pharmacy Practice, 6, 6, (297-303), (2016).https://doi.org/10.1177/089719009300600607
    Crossref
  5. Pathophysiology, Medical Management, and Acute Rehabilitation of Stroke Survivors, Stroke Rehabilitation, (2-45), (2016).https://doi.org/10.1016/B978-0-323-17281-3.00001-0
    Crossref
  6. Effects of lacosamide “a novel antiepileptic drug” in the early stages of chicken embryo development, Child's Nervous System, 32, 9, (1715-1719), (2016).https://doi.org/10.1007/s00381-016-3181-4
    Crossref
  7. Foetal safety of old and new antiepileptic drugs, Expert Opinion on Drug Safety, 14, 10, (1563-1571), (2015).https://doi.org/10.1517/14740338.2015.1084288
    Crossref
  8. Experience with vertebral artery origin stenting and ostium dilatation: results of treatment and clinical outcomes, Journal of NeuroInterventional Surgery, 8, 5, (476-480), (2015).https://doi.org/10.1136/neurintsurg-2015-011655
    Crossref
  9. Recurrent Stroke while on Antiplatelet Therapy, Neurologic Clinics, 33, 2, (475-489), (2015).https://doi.org/10.1016/j.ncl.2014.12.007
    Crossref
  10. Managing epilepsy in pregnancy, Expert Review of Obstetrics & Gynecology, 6, 6, (667-680), (2014).https://doi.org/10.1586/eog.11.66
    Crossref
  11. See more
Loading...

View Options

Get Access

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

Purchase this article to get full access to it.

Purchase Access, $39 for 24hr of access

View options

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Share article link

Share